These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33032845)

  • 1. The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Wolf J; Hansen R; Hassis K; Lapps W; Warmuth E
    Vaccine; 2020 Oct; 38(46):7198-7200. PubMed ID: 33032845
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Concepts and Technologies in Vaccine Development.
    Brisse M; Vrba SM; Kirk N; Liang Y; Ly H
    Front Immunol; 2020; 11():583077. PubMed ID: 33101309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
    Pregelj L; Hine DC; Oyola-Lozada MG; Munro TP
    Trends Biotechnol; 2020 Sep; 38(9):943-947. PubMed ID: 32600777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 7. The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2.
    Morris KV
    Mol Ther; 2020 Jul; 28(7):1548-1549. PubMed ID: 32533920
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 immunogenicity at the crossroads.
    Karamloo F; König R
    Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346
    [No Abstract]   [Full Text] [Related]  

  • 11. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19: Why Declining Biodiversity Puts Us at Greater Risk for Emerging Infectious Diseases, and What We Can Do.
    Khetan AK
    J Gen Intern Med; 2020 Sep; 35(9):2746-2747. PubMed ID: 32588178
    [No Abstract]   [Full Text] [Related]  

  • 14. The race for coronavirus vaccines: a graphical guide.
    Callaway E
    Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
    [No Abstract]   [Full Text] [Related]  

  • 15. In Pursuit of a SARS-CoV-2 Vaccine.
    Johnson AR; McDonald AR; Malay DS
    J Foot Ankle Surg; 2020; 59(6):1133-1134. PubMed ID: 33129444
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Genetic Vaccines the Right Weapon against COVID-19?
    Conforti A; Marra E; Roscilli G; Palombo F; Ciliberto G; Aurisicchio L
    Mol Ther; 2020 Jul; 28(7):1555-1556. PubMed ID: 32553431
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid COVID-19 vaccine development.
    Graham BS
    Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.